Impact of in vivo fate of STING agonist-loaded lipid nanoparticles on antitumor immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of in vivo fate of STING agonist-loaded lipid nanoparticles on antitumor immunity

Published:2024-08 Issue: Volume:372 Page:609-618
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Endo Rikito,Ueda Tomoki,Nagaoki Takumi,Shima Natsumi,Sato Yusuke,Harashima Hideyoshi,Nakamura Takashi

Funder

Ono Pharmaceutical Co Ltd

Government of Japan Ministry of Education Culture Sports Science and Technology

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Reference27 articles.

1. The cancer-immunity cycle: indication, genotype, and immunotype;Mellman;Immunity,2023

2. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors;Woo;Immunity,2014

3. Molecular mechanisms and cellular functions of cGAS-STING signalling;Hopfner;Nat. Rev. Mol. Cell Biol.,2020

4. STING agonists as cancer therapeutics;Amouzegar;Cancers (Basel),2021

5. The nanomedicine rush: new strategies for unmet medical needs based on innovative nano DDS;Sato;J. Control. Release,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP